Quantum-Si - מכפיל P/S עתידי QSI

Planned utilization of research capacities and the updating of IT infrastructure support the price action of Quantum-Si (QSI). The forward P/S ratio visualizes this trend, where the 195.30 level indicates the state of the valuation parameter. Success is based on patents in chip-based proteomics that simplify diagnostics. Stability for the business is provided by US laboratories creating breakthrough semiconductor-based protein analysis systems.

For Quantum-Si (QSI), whose scalability is based on the mass production of semiconductor chips for protein analysis, the forward P/S ratio serves as a gauge of market expectations regarding future revenue. This chart compares current market capitalization with projected annual income, allowing investors to assess the premium paid for the company's expansion potential given the low unit cost of each individual test.